The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
Healthcare operations veteran with over 23 years of experience to lead key initiatives across South India
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies
Expands manufacturing push & locks in major growth deals
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
